Evolving to meet pharma’s recruitment needs
ADVERTORIAL | Brothers Chris and Andy Anderson from Evolve share what their business has to offer in a changing pharma market to meet industry's...
eyeforpharma Barcelona goes VIRTUAL
Spotlight: Advertorial from Pf Partners
Hi Covid-19 has undoubtedly created one of the most challenging environments of the modern era. Together, we must step up to...
Are virtual meetings part of your coronavirus contingency plans?
ADVERTORIAL | Coronavirus has created worrying times around the world. As businesses set their coronavirus contingency plans, there are ways to ensure that pharma...
Impact and influence of technology in pharma recruitment
ADVERTORIAL | As online and digital technology advances, Pf talks with Andy Anderson at Evolve about the impact and influence of technology in pharma...
Shaping market opportunities to sell your solution
There is a challenge for new innovation to succeed. Nick Williams, explores how Triducive are shaping market opportunities to help you sell your solution In...
Pf Awards: The Olympics of the pharmaceutical industry
Pf Awards Judge Mark Pringle, on why he’s involved in the prestigious event. Tell me a little about yourself I’m an experienced executive coach, business...
Mapping the intricate oncology landscape
Simon Grime, of Wilmington Healthcare, explains how data and intelligence tools help pharma deliver tailored engagement programmes to diverse stakeholders in an intricate oncology...
Unpredictable times in pharma call for flexibility
Alan Kidd, a member of the CHASE Business Development team, looks how these unpredictable times in pharma call for flexibility, and how the industry...
Integrated commercial deployment in life sciences and other 2020 health trends
Syneos Health explore integrated commercial deployment in life sciences and discuss their new report covering 2020 health trends. Life science leaders aren’t launching with...
The quest for patient centricity
In the quest for patient centricity, pharmaceutical companies are working with a more extensive and increasingly diverse group of providers than ever before. Services...
Latest articles
NICE recommends Tagrisso for patients with early-stage lung cancer
Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
JCVI responds to Omicron variant and updates its guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
EC grants marketing authorisation for breast cancer treatment Trodelvy
The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
NICE recommends Tagrisso for patients with early-stage lung cancer
Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
JCVI responds to Omicron variant and updates its guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...